Newsletter Archive

  1. 05.30.25 -- EMA Issues Paper On Qualifying Non-Mutagenic Impurities For Drug Toxicological Safety 5/30/2025
    05/30/25 Pharmaceutical Online Newsletter
  2. 05.29.25 -- 8 Actions To Redefine Sponsor–CDMO Relationships 5/29/2025
    05/29/25 Pharmaceutical Online Newsletter
  3. 05.29.25 -- STREAM Edition: When To Think About Utilities In Facility Design 5/29/2025

    05/29/25 Pharmaceutical Online Newsletter

  4. 05.28.25 -- Cost-Saving Strategies For Drug Manufacturers And CDMOs 5/28/2025

    05/28/25 Pharmaceutical Online Newsletter

  5. 05.27.25 -- Navigating NDSRI Compliance And Optimizing API Purification 5/27/2025

    05/27/25 Pharmaceutical Online Newsletter

  6. 05.27.25 -- Pharma 4.0 Adoption Needs Cooperation — Here's How To Build It 5/27/2025
    05/27/25 Pharmaceutical Online Newsletter
  7. 05.23.25 -- Ensure Quality With Process Equipment Providers 5/23/2025
    05/23/25 Pharmaceutical Online Newsletter
  8. 05.23.25 -- What FDA Draft Guidance Tells Us About In-Process Control Strategies 5/23/2025
    05/23/25 Pharmaceutical Online Newsletter
  9. 05.22.25 -- Discover Secondary Packaging Service Providers & Suppliers 5/22/2025
    05/22/25 Pharmaceutical Online Newsletter
  10. 05.22.25 -- Combination Products: U.S. Vs. EU Requirements And A Harmonized Strategy To Prepare CTD Module 3 5/22/2025
    05/22/25 Pharmaceutical Online Newsletter